CHEMO-FREE HOPE: new trial tests skipping Post-Surgery drugs for colorectal cancer

NCT ID NCT03748485

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is looking at whether people with locally advanced colorectal cancer who have already received chemotherapy or radiation before surgery can safely skip additional chemotherapy afterward. The trial will compare a 'wait and watch' approach to standard adjuvant chemotherapy in 650 participants whose cancer has been down-staged to stage II after pre-surgery treatment. The goal is to see if avoiding extra chemo can maintain similar outcomes while reducing side effects.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
adjuvant chemotherapy (mFOLFOX6)
What this could lead to
If successful, this could show that some patients with locally advanced colorectal cancer can safely avoid additional chemotherapy after pre-surgery treatment, reducing side effects.
What could go wrong
This is an early-stage trial with no phase designation, and the benefit of skipping chemo is uncertain. The results may not apply to all patients, and there is a risk of cancer recurrence without chemotherapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADJUVANT CHEMOTHERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sixth Affiliated Hospital of Sun Yat-sen University

    RECRUITING

    Guangzhou, Guangdong, 510655, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.